S200: IMPROVED OVERALL SURVIVAL WITH FIRST-LINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH STAGE III/IV CLASSICAL HODGKIN LYMPHOMA: 6-YEAR ANALYSIS OF ECHELON-1
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 101-102
10.1097/01.hs9.0000843692.94815.d7